ESCRS - IOL IMPLANTATION

IOL IMPLANTATION

IOL IMPLANTATION

IOL implantation can be safely delayed for several months in eyes undergoing cataract removal for improved visualisation during vitreoretinal surgery, a new study shows. The study involved a consecutive case of 21 eyes implanted with IOLs 1.5 months to 19 months after undergoing phacoemulsification. All but one case underwent phacoemulsification to facilitate a vitreoretinal procedure and all were free of severe capsular fibrosis. At one month’s follow-up, the refractive mean error was +0.06 D and the mean absolute error was +0.24 D. The authors noted that the postoperative refractive results were comparable with those of routine cataract surgery. They added that delaying surgery could reduce the amount of biometric errors such as can occur in eyes with a detached retina

(Chen et al, Ophthalmologica 2012; 227:80–84).

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...